Clinical assessment of hepatic functional reserve using 99mTc DTPA galactosyl human serum albumin SPECT to prognosticate chronic hepatic diseases--validation of the use of SPECT and a new indicator.

MLA

Onodera, Yuya, et al. “Clinical Assessment of Hepatic Functional Reserve Using 99mTc DTPA Galactosyl Human Serum Albumin SPECT to Prognosticate Chronic Hepatic Diseases--Validation of the Use of SPECT and a New Indicator.” Annals of Nuclear Medicine, vol. 17, no. 3, May 2003, pp. 181–88. EBSCOhost, https://doi.org/10.1007/BF02990020.

APA

Onodera, Y., Takahashi, K., Togashi, T., Sugai, Y., Tamaki, N., & Miyasaka, K. (2003). Clinical assessment of hepatic functional reserve using 99mTc DTPA galactosyl human serum albumin SPECT to prognosticate chronic hepatic diseases--validation of the use of SPECT and a new indicator. Annals of Nuclear Medicine, 17(3), 181–188. https://doi.org/10.1007/BF02990020

Chicago

Onodera, Yuya, Kazuei Takahashi, Tadashi Togashi, Yukio Sugai, Nagara Tamaki, and Kazuo Miyasaka. 2003. “Clinical Assessment of Hepatic Functional Reserve Using 99mTc DTPA Galactosyl Human Serum Albumin SPECT to Prognosticate Chronic Hepatic Diseases--Validation of the Use of SPECT and a New Indicator.” Annals of Nuclear Medicine 17 (3): 181–88. doi:10.1007/BF02990020.